Proteome Systems' IPO opens

By Graeme O'Neill
Tuesday, 24 August, 2004

Australian investors can now buy a piece of North Ryde-based biotechnology company Proteome Systems, the Australian company credited with pioneering the latter-day boom science of proteomics.

Proteome Systems today announced the opening of its initial public offering on the Australian Stock Exchange, which values the company at $120 million.

The company’s founder, Dr Keith Williams, spun the company out of Macquarie University in 1999 to commercialise tools for researchers in the emerging science of functional genomics. It was Williams’ former PhD student, Marc Wilkins -- now the company’s head of bioinformatics -- who coined the term 'proteomics'.

The company has developed an integrated suite of tools and consumables for isolating, identifying and characterizing proteins, around mass spectrometers supplied by its Japanese partner Shimadzu. Proteome's proprietary plug-and-play bioinformatics system, developed in partnership with IBM, completes the package.

Proteome’s IPO is fully underwritten by Patersons Securities, and Foster Stockbroking is broker to the offer.

Related News

Why a gluten-free diet fails in some coeliac patients

Abnormal immune cells are driving ongoing intestinal inflammation that causes symptoms like...

Giving rotavirus vaccine at birth benefits gut bacteria

Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good...

TGA approves donanemab for treatment of early Alzheimer's

The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd